R&D How lab automation reinforces regulatory compliance for bioa... Automation holds the potential to enhance scientific rigour and operational efficiency while solving long-standing regulatory conundrums.
R&D Unlocking the future of neurodegeneration research: How auto... On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.
Digital We can’t fix modern healthcare with 1950s solutions. AI is t... In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.
Digital Understanding how technology fits into the evolving role of ... As technology reshapes healthcare, pharmacists are leveraging automation, telehealth, and digital tools to transform how care is delivered
R&D When costing and compliance collide Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
